Manufacturer record

Concord Drugs Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by Concord Drugs Ltd (Telangana) were declared Not of Standard Quality between September 2020 and February 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

2 records linked to Concord Drugs Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Sep 2020 to Feb 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2020
2
Products affected
Misbranded
Most common failure
Feb 2025
Latest alert

Flagged batches per year

2020 · 12025 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Moovrun tablets Diclofenac Sodium and Paracetamol tablets DFP- 2403Mfg 2024-01 · Exp 2025-12 MISBRANDED DRUG The drug product Diclofenac sodium and Paracetamol tablets is offcially included in the current edition of Indian Pharmacopoeia IP 2022 and as required as per second schedule of the Drugs and Cosmetics Act, 1940 the said Product shall comply with the standards set out in the Indian Pharmacopoeia. But the designation IP in conjunction with the offcial title Diclofenac sodium and Paracetamol tablets on the label of the drug product was not mentioned as an indication that the drug product purports to comply with the IP satadards. Hence the drug product shall deemed to be MISBRANDED DRUG as per section 17 of Drugs and Cosmetics Act, 1940 as it is not labelled in the prescribed Manner.Misbranded State Lab Drugs Control Laboratory, TelanganaState lab Feb 2025
ROOTCAL ((Calcium Citrate Malate & Vitamin D3 Tablets) RTC-1910Mfg 2019-10 · Exp 2021-09 Disintegration and Assay of Vitamin D3Assay CDL KolkataCDSCO lab Sep 2020

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.